Pay in 4 interest-free payments of $6.62 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
The Bottom Line GLP-1 medications have already reshaped the weight-health landscape
PMID 17426848
Another TKI, gefitinib (ZD1839, Iressa), which targets the epidermal growth factor receptor (EGFR), has been shown to restrict M.tb replication in both macrophages as well as in the lungs of M.tb -infected mice by promoting the host autophagy pathway through the inhibition of the p38 MAPK signaling pathway activated by EGFR [10]
10.1007/s00125-004-1498-0 36 RobertK.VialardF.ThieryE.ToyamaK.SinetP.JanelN.et al
US$ 21.65
US$ 23.15
US$ 20.13
US$ 27.15
US$ 29.89
